Eli Lilly (LLY) EV to EBIT (2009 - 2026)
Eli Lilly's EV to EBIT was 25.28 in Q3 2026, down 8.9% from 27.74 a year earlier and down 13.8% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EV to EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's EV to EBIT was 24.78 through Sep 30, 2026, down 9.4% year-over-year; for FY2025, it came in at 34.46, down 23.5% from FY2024.
- In earlier years, EV to EBIT was 45.04 in FY2024 (-16.2%), 53.72 in FY2023 (+24.9%), 43.00 in FY2022 (+21.5%) and 35.39 in FY2021 (+52.6%).
- The Q3 2026 figure marks the lowest quarterly EV to EBIT since Q4 2020.
- Compared with a year earlier, EV to EBIT has declined for eight straight quarters, with an average decline of 29.9% over the last eight quarters.
- The best year-over-year quarter for EV to EBIT over five years was Q2 2023 (growth of 63.8%); the worst was Q3 2025 (a decline of 54.1%).
- Per Business Quant data, LLY's EV to EBIT in the three quarters before Q3 2026 was 29.34 (Q2 2026), 25.74 (Q1 2026) and 34.46 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 25.28 |
| Jun 30, 2026 | 29.34 |
| Mar 31, 2026 | 25.74 |
| Dec 31, 2025 | 34.46 |
| Sep 30, 2025 | 27.74 |
| Jun 30, 2025 | 33.41 |
| Mar 31, 2025 | 41.41 |
| Dec 31, 2024 | 45.04 |
| Sep 30, 2024 | 60.47 |
| Jun 30, 2024 | 66.33 |
| Mar 31, 2024 | 65.34 |
| Dec 31, 2023 | 53.72 |
| Sep 30, 2023 | 54.43 |
| Jun 30, 2023 | 57.93 |
| Mar 31, 2023 | 45.64 |
| Dec 31, 2022 | 43.00 |
| Sep 30, 2022 | 36.64 |
| Jun 30, 2022 | 35.38 |
| Mar 31, 2022 | 31.99 |
| Dec 31, 2021 | 35.39 |
API Access
Eli Lilly EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();